SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001144204-17-011003
Filing Date
2017-02-24
Accepted
2017-02-24 17:00:54
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM F-1 v460235_f1.htm F-1 1482844
2 EXHIBIT 23.1 v460235_ex23-1.htm EX-23.1 3146
3 GRAPHIC logo_20f.jpg GRAPHIC 2077
4 GRAPHIC logo_f1.jpg GRAPHIC 5446
5 GRAPHIC pg123img1_f1.jpg GRAPHIC 14022
6 GRAPHIC pg61img1_f1.jpg GRAPHIC 73353
7 GRAPHIC pg62img1_f1.jpg GRAPHIC 120286
8 GRAPHIC pg65img1_f1.jpg GRAPHIC 58890
  Complete submission text file 0001144204-17-011003.txt   1865399
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Bioblast Pharma Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-216238 | Film No.: 17638225
SIC: 2834 Pharmaceutical Preparations